Mouwasat Medical Services
SAR 62.25Change from previous close: −0.72%Absolute change: −SAR 0.45
Valuation
Data as of October 3, 2026
Valuation multiples
- Market cap
- SAR 12.54B
- Enterprise value
- SAR 13.71B
- P/E (trailing 12 months)
- 14.8
- Forward P/E
- 14.3
- Price/book
- 3.16
- Price/sales
- 3.72
- EV/EBITDA
- 11.9
- EV/revenue
- 4.07
Profitability and growth
- Gross margin
- 40.5%
- Operating margin
- 26.2%
- Net margin
- 25.2%
- ROE
- 22.6%
- ROA
- 9.2%
- Revenue growth (year over year)
- 10.1%
- Earnings growth (year over year)
- 14.0%
Financial health
- Total cash
- SAR 158.99M
- Total debt
- SAR 1.18B
- Debt/equity
- 0.29
- Current ratio
- 1.51
- Quick ratio
- 1.19
Dividends
- Annual dividend per share
- SAR 4.13
- Dividend yield
- 6.6%
- Payout ratio
- 50.0%
- Ex-dividend date
- May 5, 2026
Analysts and estimates
- Average price target
- SAR 81.91
- Median price target
- SAR 83.00
- High price target
- SAR 106.00
- Low price target
- SAR 62.00
- Analysts with a price target
- 13
- Consensus
- Buy
- Forward EPS
- SAR 4.39
- EPS estimate, current year
- SAR 4.24
Shares and trading
- Beta
- 0.09
- Average volume
- 393.78K
- Shares outstanding
- 200M
- Float
- 90.76M
- Institutional ownership
- 7.3%
- Insider ownership
- 54.6%